Organogenesis Awards Annual Regenerative Medicine College Scholarship to Canton High School Senior

CANTON, MA – August 18, 2011—Organogenesis, Inc. has awarded its annual scholarship program for a Canton High School graduating senior pursuing a career in life sciences research or biomedical engineering. The 2011 recipient is John-Paul Burega, who will be attending Bridgewater State University in the fall with a concentration in biochemistry.

Gary S. Gillheeney, Sr., CFO and COO of Organogenesis (l.), presents the 2011 Regenerative Medicine Scholarship to Canton High School graduating senior John-Paul Burega, with Canton High School principal Dr. Doug Dias (r.).

John-Paul graduated Canton High School with a GPA of 3.78. In addition to his academic career, John-Paul was also active in the drama club at CHS.

"We are proud to support John-Paul in pursuing his academic and career goals," said Gary S. Gillheeney, Sr., Executive Vice President, Chief Operating Officer and Chief Financial Officer of Organogenesis. "We hope his example will inspire other talented students to consider a career in the sciences."

The Organogenesis Scholarship of $2,500 is awarded on the basis of academic achievement and content of an essay, How do you see yourself contributing to the future of the Life Sciences? John-Paul's essay detailed his hopes to prepare for a future career as a research scientist with a leading hospital, and to contribute to medical advances that will benefit patients with cancer and with HIV.

About Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing and bio-surgery. The company’s mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. The company’s lead product, Apligraf^®, a bilayered living cellular construct to treat non-healing wounds, has been used to treat hundreds of thousands of patients. For more information, visit
www.organogenesis.com.

» Back to Press Releases and Announcements